1. Home
  2. RIVN vs HOLX Comparison

RIVN vs HOLX Comparison

Compare RIVN & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rivian Automotive Inc.

RIVN

Rivian Automotive Inc.

HOLD

Current Price

$15.44

Market Cap

18.3B

ML Signal

HOLD

Logo Hologic Inc.

HOLX

Hologic Inc.

HOLD

Current Price

$76.02

Market Cap

16.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RIVN
HOLX
Founded
2009
1985
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Medical Electronics
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.3B
16.9B
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
RIVN
HOLX
Price
$15.44
$76.02
Analyst Decision
Buy
Hold
Analyst Count
21
13
Target Price
$17.74
$77.89
AVG Volume (30 Days)
24.4M
8.6M
Earning Date
04-30-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
34.54
N/A
EPS
N/A
0.79
Revenue
$5,387,000,000.00
$4,100,500,000.00
Revenue This Year
$32.97
$4.74
Revenue Next Year
$64.29
$5.03
P/E Ratio
N/A
$96.23
Revenue Growth
8.39
1.74
52 Week Low
$10.85
$51.90
52 Week High
$22.69
$76.07

Technical Indicators

Market Signals
Indicator
RIVN
HOLX
Relative Strength Index (RSI) 50.96 69.09
Support Level $14.20 $75.10
Resistance Level $16.17 N/A
Average True Range (ATR) 0.75 0.19
MACD 0.02 0.03
Stochastic Oscillator 52.41 95.19

Price Performance

Historical Comparison
RIVN
HOLX

About RIVN Rivian Automotive Inc.

Rivian is a battery electric vehicle automaker that sells its vehicles in the US and Canada. The company also develops electronic control units and related software for autos in a joint venture with Volkswagen. Rivian has multiple vehicles in its fleet, which include a luxury truck and full-size SUV and a delivery van. The company plans to begin selling a midsize SUV in 2026. Total deliveries were over 42,000 in 2025. Rivian is also developing autonomous driving software to be used in its vehicles.

About HOLX Hologic Inc.

Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.

Share on Social Networks: